Evolent Health, Inc.
EVH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,290 | $3,675 | $2,631 | $2,381 |
| - Cash | $104 | $193 | $188 | $266 |
| + Debt | $714 | $645 | $476 | $280 |
| Enterprise Value | $1,900 | $4,127 | $2,919 | $2,396 |
| Revenue | $2,555 | $1,964 | $1,352 | $908 |
| % Growth | 30.1% | 45.3% | 48.9% | – |
| Gross Profit | $367 | $460 | $317 | $250 |
| % Margin | 14.4% | 23.4% | 23.4% | 27.6% |
| EBITDA | $85 | -$25 | $44 | $56 |
| % Margin | 3.3% | -1.3% | 3.2% | 6.1% |
| Net Income | -$62 | -$113 | -$19 | -$38 |
| % Margin | -2.4% | -5.8% | -1.4% | -4.1% |
| EPS Diluted | -0.81 | -1.28 | -0.2 | -0.36 |
| % Growth | 36.7% | -540% | 44.4% | – |
| Operating Cash Flow | $19 | $143 | -$12 | $39 |
| Capital Expenditures | -$25 | -$29 | -$38 | -$25 |
| Free Cash Flow | -$6 | $114 | -$50 | $14 |